NCT00244296已完成4 期
A Double-Blind, Stratified, Randomised, Parallel, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy and Safety of Duloxetine (20 mg Bid for 2 Weeks Escalating to 40 mg Bid) for up to 12 Weeks, Compared to Placebo, in Community-Dwelling Elderly Women > or = 65 Years of Age With Symptoms of Stress Urinary Incontinence or Stress-Predominant Mixed Urinary Incontinence.
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 276
- 试验地点
- 31
- 主要终点
- Assess the efficacy of duloxetine for up to 12 weeks, compared to placebo, in community dwelling women > or = 65 years of age with symptoms of pure stress urinary incontinence (SUI) or stress-predominant mixed urinary incontinence
研究概览
简要总结
The purpose of this study is to determine how effective duloxetine is in treating women who are 65 years of age or older with symptoms of stress urinary incontinence, or with a combination of stress urinary incontinence and urge urinary incontinence symptoms.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •female outpatient greater than or equal to 65 years of age
- •have symptoms of SUI or stress-predominant MUI for at least 3 consecutive months
- •have at least 7 incontinence episodes per week. For patients with MUI, at least 50% of the IEF must be due to stress.
- •is ambulatory and able to use a toilet independently and without difficulty
排除标准
- •at Visit 1 have a positive urine culture or a history of four or more urinary tract infections (UTIs) in the preceding year
- •have had continence surgery or received bladder neck bulking agent therapy within 3 months prior to study entry
- •began pelvic floor muscle exercises (for example, Kegel or biofeedback) within 3 months prior to study entry or at any time during the study.
- •have neurologic lesions or conditions (e.g. multiple sclerosis, spinal cord lesions or Parkinson's disease) or local lesions (e.g. bladder stones present or tumors) that affect the lower urinary tract.
- •intake of monoamine oxidase inhibitors (MAOIs) within 14 days prior to randomisation or at any time during the study
结局指标
主要结局
Assess the efficacy of duloxetine for up to 12 weeks, compared to placebo, in community dwelling women > or = 65 years of age with symptoms of pure stress urinary incontinence (SUI) or stress-predominant mixed urinary incontinence
次要结局
- Compare the efficacy of duloxetine 40 mg twice daily with that of placebo in the treatment of the symptoms of SUI and stress-predominant MUI as measured by:Absolute change in IEF
- Change in mean time between voids
- Percent change in the number of continence pads used per week
- Change in the Incontinence Quality of Life total score and 3 sub-domain scores
- Responder analysis based on the established within-treatment minimal clinically important difference established for the I-QOL
- Responder analysis based on percent change in IEF
- Patient's rating of improvement using the PGI-I
- Compare efficacy of duloxetine 40 mg twice daily with that of placebo as measured by the percent change in IEF using in the SUI and MUI subgroups
- To assess the impact of treatment with duloxetine 40 mg twice daily and placebo on the development of suicidal ideation.
- Assess the impact of treatment with duloxetine 40 mg twice daily and placebo in cognition.
- Assess the impact of treatment with duloxetine 40 mg twice daily and placebo as measured by changes in BDI-II.
- To compare the safety of duloxetine with placebo based on changes in vital signs, clinical lab values, occurrence and duration of adverse events and premature discontinuation of study due to adverse events.
研究者
研究点 (31)
Loading locations...
相似试验
已完成
4 期
Comparison of the Efficacy of Duloxetine With Placebo in Patients With Chronic Low Back Pain With a Radicular ComponentChronic Low Back PainNCT01166048Medical University of Vienna41
已完成
4 期
A Study for Adult Patients With FibromyalgiaFibromyalgia, PrimaryFibromyalgia, SecondaryNCT00965081Eli Lilly and Company308
已完成
2 期
Double Blind Trial of Duloxetine in Chronic Fatigue SyndromeFatigue Syndrome, ChronicNCT00375973University of Cincinnati60
已完成
4 期
Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.Stress Urinary IncontinenceNCT00190905Eli Lilly and Company4,000
已完成
3 期
A Study in Pediatric Participants With Generalized Anxiety DisorderAnxiety NeurosesAnxiety States, NeuroticNeuroses, AnxietyNCT01226511Eli Lilly and Company281